Meeting
Abstract Number: 269
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The use of IV insulin is one of the primary therapeutic options for the treatment of hyperkalemia. Unfortunately the available literature reports that hypoglycemia is a common occurrence as a result of the treatment of hyperkalemia. During our safety event review process, we identified the same issue within our own institution. Due to reports […]